At the news
? NEUTRALIMPACT 2/10 8-K filed Aug 17, 2026 at 07:30 ET
Profound Medical announced the resignation of CFO Rashed Dewan and the appointment of Corporate Controller Matthew Sobczyk as Interim CFO, effective August 14, 2026. The CFO departure is orderly with a transition consulting agreement, and the interim CFO is an internal promotion with deep company knowledge, making this a routine management change with no immediate financial impact on operations.
- CFO Rashed Dewan resigned effective August 14, 2026.
- Matthew Sobczyk, previously Corporate Controller, appointed Interim CFO effective same date.
- Dewan will serve as a consultant from August 17 to November 25, 2026, receiving CAD 200/hour + continued vesting of 20,000 RSUs.
- Dewan receives a $375,000 cash severance payment.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access